Edwards Catheter Wins FDA Approval
Dow Jones
Edwards Lifesciences Corp. in Irvine received Food and Drug Administration approval to begin selling its Vantex central venous catheter. Shares of the company, which develops products and services to treat late-stage cardiovascular disease, rose $1.19, or nearly 7%, to $19, on the New York Stock Exchange.